Medicines Co. (MDCO) Reports Q2 Loss of $0.63/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Medicines Co. (MDCO) Reports Q2 Loss of $0.63/Share

The Medicines Company Reports Second-Quarter 2018 Results

August 1, 2018 7:00 AM EDT

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today reported its financial results for the second quarter ended June 30, 2018.

During the second quarter of 2018, we continued to advance inclisirans development programs, including the accumulation of further promising safety data from 3,660 patients in Phase III trials, said Clive Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines Company. We were also able to present consistent phase II subset efficacy data in various demographic and disease populations for LDL-C and other atherogenic lipoproteins. We look forward to further progress in... More